NASDAQ:MIRM

Mirum Pharmaceuticals Stock Insider Trading

etoro logo Buy MIRM
*Your capital is at risk
$91.84
-0.335 (-0.363%)
At Close: Jun 03, 2026

Mirum Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -1.73. In total, the insiders bought 1.17M and sold 157.01K MIRM shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-1.73
Buy 1.17M shares
Sell 157.01K shares
72% Buy Activity
Negligible or No Correlation
Buy Signal Low Confidence
Jan 28, 2026

Analysis Breakdown:

  • Weakened by a contradictory negative Insider Power Score.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Feb 13, 2026
Buy
Common Stock
M-Exempt
Ramasastry Saira
Director
Director 2 000
Value: $47.0K
Feb 13, 2026
Sell
Common Stock
S-Sale
Ramasastry Saira
Director
Director 2 000
Value: $204.2K
Feb 02, 2026
Sell
Common Stock
S-Sale
Howe Jolanda
SVP, Global Controller
Officer 968
Value: $100.0K
Feb 02, 2026
Sell
Common Stock
S-Sale
Peetz Christopher
Chief Executive Officer
CEO / President 9 108
Value: $940.9K
Feb 02, 2026
Sell
Common Stock
S-Sale
Radovich Peter
President And COO
CEO / President 2 631
Value: $271.8K
Jan 31, 2026
Buy
Restricted Stock Units
M-Exempt
Howe Jolanda
SVP, Global Controller
Officer 1 771
Value: $162.6K
Jan 31, 2026
Buy
Common Stock
M-Exempt
Howe Jolanda
SVP, Global Controller
Officer 1 771
Value: $162.6K
Jan 28, 2026
Buy
Restricted Stock Units
A-Award
Bjerkholt Eric
Chief Financial Officer
C-Suite Officer 11 760
Value: $1.19M
Jan 28, 2026
Buy
Stock Option (right to buy)
A-Award
Bjerkholt Eric
Chief Financial Officer
C-Suite Officer 18 140
Value: $1.83M
Jan 28, 2026
Buy
Performance Restricted Stock Units
A-Award
Bjerkholt Eric
Chief Financial Officer
C-Suite Officer 20 000
Value: $2.02M
Jan 28, 2026
Buy
Restricted Stock Units
A-Award
Quan Joanne
Chief Medical Officer
Officer 11 760
Value: $1.19M
Jan 28, 2026
Buy
Stock Option (right to buy)
A-Award
Quan Joanne
Chief Medical Officer
Officer 18 140
Value: $1.83M
Jan 28, 2026
Buy
Performance Restricted Stock Units
A-Award
Quan Joanne
Chief Medical Officer
Officer 20 000
Value: $2.02M
Jan 28, 2026
Buy
Performance Restricted Stock Units
A-Award
Howe Jolanda
SVP, Global Controller
Officer 9 000
Value: $907.7K
Jan 28, 2026
Buy
Stock Option (right to buy)
A-Award
Howe Jolanda
SVP, Global Controller
Officer 7 680
Value: $774.5K
Jan 28, 2026
Buy
Restricted Stock Units
A-Award
Howe Jolanda
SVP, Global Controller
Officer 4 970
Value: $501.2K
Jan 28, 2026
Buy
Performance Restricted Stock Units
A-Award
Radovich Peter
President And COO
CEO / President 34 500
Value: $3.48M
Jan 28, 2026
Buy
Stock Option (right to buy)
A-Award
Radovich Peter
President And COO
CEO / President 25 120
Value: $2.53M
Jan 28, 2026
Buy
Restricted Stock Units
A-Award
Radovich Peter
President And COO
CEO / President 16 280
Value: $1.64M
Jan 28, 2026
Buy
Performance Restricted Stock Units
A-Award
Peetz Christopher
Chief Executive Officer
CEO / President 75 000
Value: $7.56M
Jan 28, 2026
Buy
Stock Option (right to buy)
A-Award
Peetz Christopher
Chief Executive Officer
CEO / President 67 000
Value: $6.76M
Jan 28, 2026
Buy
Restricted Stock Units
A-Award
Peetz Christopher
Chief Executive Officer
CEO / President 43 500
Value: $4.39M
Jan 26, 2026
Sell
Common Stock
S-Sale
Peetz Christopher
Chief Executive Officer
CEO / President 6 831
Value: $657.1K
Jan 26, 2026
Sell
Common Stock
S-Sale
Howe Jolanda
SVP, Global Controller
Officer 842
Value: $81.0K
Jan 26, 2026
Sell
Common Stock
S-Sale
Bjerkholt Eric
Chief Financial Officer
C-Suite Officer 1 053
Value: $101.3K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT MIRUM PHARMACEUTICALS, INC.
Mirum Pharmaceuticals
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of Alagille syndrome and biliary atresia disease. It also develops Volixibat drug for treatment o...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE